NAS
MANE

Nykredit A/S’s Veradermics Inc MANE Stock Holding History

Nykredit A/S’s Portfolio MANE Stock Details MANE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.2K Buy
+164
New +$15.4K ﹤0.01% 1733

Other funds holding MANE

SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nykredit A/S's MANE Position: Q2 2026 in Review

Nykredit A/S opened a new position in Veradermics Inc (MANE) in Q2 2026: 164 shares worth $20.2K. The stake represents ﹤0.01% of the portfolio and ranks #1733 among its holdings.

93 funds tracked by Wall St. Rank hold MANE as of Q2 2026.

  • Nykredit A/S held 164 shares of Veradermics Inc worth $20.2K as of Q2 2026.
  • Veradermics Inc was a new Nykredit A/S position in Q2 2026.
  • Veradermics Inc made up ﹤0.01% of Nykredit A/S's portfolio in Q2 2026, its #1733 holding.
  • 93 funds tracked by Wall St. Rank held Veradermics Inc as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.